Inhibitory effects of PL on NF-κB activity have been reported in atherosclerotic plaque formation and in the prevention of Burkitt lymphoma and prostate cancer cell growth (Son et al. 2012; Han et al. 2013; Ginzburg et al. 2014). This evidence concerns the gene NFKB1 and prostate carcinoma.